Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans

Journal of Virological Methods

Volumn 146, Issue 1-2, 2007, Pages 119-124

  Paweska, Janusz T ^a   Jansen van Vuren, Petrus ^a   Swanepoel, Robert ^a  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

Humans; IgG antibody; Indirect ELISA; Recombinant nucleocapsid antigen; Rift Valley fever virus; Validation

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; NUCLEOCAPSID PROTEIN;

ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD ANALYSIS; BUNYAVIRUS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; HUMAN; HUMAN CELL; MOUSE; NAIRO VIRUS; NONHUMAN; ORTHOBUNYAVIRUS; PHLEBOVIRUS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RIFT VALLEY FEVER BUNYAVIRUS; VALIDATION STUDY; VIRUS NEUTRALIZATION;

AFRICA; ANTIBODIES, VIRAL; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; NUCLEOCAPSID; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; SENSITIVITY AND SPECIFICITY;

BHANJA VIRUS; BUNYAVIRIDAE; MUS; NAIROVIRUS; ORTHOBUNYAVIRUS; PHLEBOVIRUS; RIFT VALLEY FEVER VIRUS;

EID: 35648982327     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.06.006     Document Type: Article

References (38)

1. Bishop D.H., Calisher C.H., Casals J., Chumakov M.P., Gaidamovich S.Y., Hannoun C., Lvov D.K., Marshall I.D., Oker-Blom N., Pettersson R.F., Porterfield J.S., Russell P.K., Shope R.E., and Westaway E.G. Bunyaviridae. Intervirology 14 (1980) 125-143
2. Bolton D.C., Chu H.-J., Ardans A.A., Kelly B., and Zee Y.C. Evaluation of the critical parameters of a sensitive ELISA test using purified infectious bovine rhinotracheitis antigen. Vet. Microbiol. 6 (1981) 265-279
3. Brenner H., and Gefeller O. Variation of sensitivity, specificity, likelihood rations and predictive values with disease prevalence. Stat. Med. 16 (1997) 981-991
4. Burt F.J., Swanepoel R., and Braack L.E. Enzyme-linked immunosorbent assay for the detection of antibody to Crimean-Congo haemorrhagic fever virus in the sera of livestock and wild vertebrates. Epidemiol. Infect. 111 (1993) 547-557
5. Centers for Disease Control and Prevention, 2007. Rift Valley fever outbreak in Kenya, November 2006-January 2007. MMWR Morb. Mortal. Wkly. Rep. 2007, 56, 73-76.
6. Deshpande S.S. Assay development, evaluation and validation. In: Deshpande (Ed). Enzyme Immunoassays. From Concept to Product Development (1996), Chapman & Hall, New York 275-359
7. Fafetine J.M., Tijhaar E., Paweska J.T., Newes L.C.B.G., Hendrings J., Swanepoel R., Coetzer J.A.W., Egbering H.F., and Rutten V.P.M.G. Cloning and expression of Rift Valley fever virus nucleocapsid (N) protein and evaluation of a N-protein based indirect ELISA for the detection of specific IgG and IgM antibodies in domestic ruminants. Vet. Microbiol. 121 (2007) 29-38
8. Findlay G.M., and Howard E.M. Notes on Rift Valley fever. Archiv für die Gesamte Virusforschung 4 (1951) 412-423
9. Forghani B., and Schmidt R.E. Detection of antibodies to alphavirus by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 10 (1979) 583-585
10. Gravell M., Dorsett P.H., Gutenson O., and Ley A.C. Detection of antibody to rubella virus by enzyme-linked immunosorbent assay. J. Infect. Dis. 136 Suppl. (1977) 300-303
11. Greiner M. Two-graph receiver operating characteristics (TG-ROC)-a Microsoft-Excel template for the selection of cut-off values in diagnostic tests. J. Immunol. Methods 185 (1995) 145-146
12. Greiner M. Two-graph receiver operating characteristics (TG-ROC): update version supports optimisation of cut-off values that minimize overall misclassification costs. J. Immunol. Methods 191 (1996) 93-94
13. Greiner M., Sohr D., and Göbel P. A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J. Immunol. Methods 185 (1995) 123-132
14. Gauliard N., Billecocq A., Flick R., and Bouloy M. Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis. Virology 351 (2006) 170-179
15. Jacobson R.H. Validation of serological assays for diagnosis of infectious diseases. Rev. Sci. Tech. Off. Int. Epizoot. 17 (1998) 469-486
16. Jacobson R.H. Principles of Validation of Diagnostic Assays for Infectious Diseases, in OIE Manual of Standards for Diagnostic Tests and Vaccines. 4th ed. (2000), Office International des Epizooties, Paris, France pp. 10-17
17. Jansen van Vuren P., Potgieter A.C., Paweska J.T., and Van Dijk A.A. Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals. J. Virol. Methods 140 (2007) 106-114
18. Jupp P.G., Kemp A., Grobbelaar A., Leman P., Burt F.J., Alahmed A.M., Al Mujalli D., Al Khamess M., and Swanepoel R. The 2000 epidemic of Rift Valley fever in Saudi Arabia: mosquito vector studies. Med. Vet. Entomol. 16 (2002) 245-252
19. Lim D.V., Simpson J.M., Kearns E.A., and Kramer M.F. Current and developing technologies for monitoring agents of bioterrorism and biowarfare. Clin. Microbiol. Rev. 18 (2005) 583-607
20. Kitchen S.F. Laboratory infections with the virus of Rift Valley fever. Am. J. Trop. Med. Hyg. 14 (1934) 547-564
21. Magurano F., and Nicoletti L. Humoral response in Toscana virus acute neurologic disease investigated by viral-protein-specific immmunoassays. Clin. Diagn. Lab. Immunol. 6 (1999) 55-60
22. Paweska J.T., Smith S.J., Wright I.M., Williams R., Cohen A.S., Van Dijk A.A., Grobbelaar A.A., Croft J.E., Swanepoel R., and Gerdes G.H. Indirect enzyme-linked immunosorbent assay for the detection of antibody against Rift Valley fever virus in domestic and wild ruminant sera. Onderstepoort J. Vet. Res. 70 (2003) 49-64
23. Paweska J.T., Burt F.J., Anthony F., Simith S.J., Grobblaar A.A., Croft J.E., Ksiazek T., and Swanepoel R. IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for detection of antibody to Rift Valley fever in domestic ruminants. J. Virol. Methods 113 (2003) 103-112
24. Paweska J.T., Burt F.J., and Swanepoel R. Validation of enzyme-linked immunosorbent assay for the detection of IgG and IgM antibody to Rift Valley fever virus in humans. J. Virol. Methods 124 (2005) 173-181
25. Paweska J.T., Mortimer E., Leman P.A., and Swanepoel R. An inhibition enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever in humans, domestic and wild ruminants. J. Virol. Methods 127 (2005) 10-18
26. Peters C.J. Are hemorrhagic viruses practical agents for biological terrorism?. In: Scheld W.M., and Craig W.A. (Eds). Emergind Infections (2000), ASM Press, Washington, DC 203-211
27. Saunders G.C., Clinard E.H., Bartlett M.L., and Sanders W.M. Application of the indirect enzyme-labeled antibody microtest to the detection and surveillance of animal diseases. J. Infect. Dis. Suppl. 136 (1977) S258-S266
28. Schrijver R.S., and Kramps J.A. Critical factors affecting the diagnostic reliability of enzyme-linked immunosorbent assay formats. Rev. Sci. Tech. Int. Epizoot. 17 (1998) 550-661
29. Schwarz T.F., Gilch S., Pauli C., and Jager G. Immunoblot detection of antibodies to Toscana virus. J. Med. Virol. 49 (1996) 83-86
30. Shoemaker T., Boulianne C., Vincent M.J., Pezzanite L., Al-Qahtani M.M., Al-Mazrou Y., Khan A.S., Rollin P.E., Swanepoel R., Ksiazek T.G., and Nichol S.T. Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen 2000-2001. Emerg. Infect. Dis. 12 (2002) 1415
31. Sidwell R.W., and Smee D.F. Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res. 57 (2003) 101-111
32. Smithburn K.C., Mahaffy A.F., Haddow A.J., Kitchen S.F., and Smith J.F. Rift Valley fever accidental infections among laboratory workers. J. Immunol. 62 (1949) 213-227
33. Swanepoel R., and Coetzer J.A.W. Rift Valley fever. In: Coetze J.A.W., and Tustin R.C. (Eds). Infectious Diseases of Livestock vol. 2 (2004), Oxford University Press, Cape Town 1037-1070
34. Swanepoel R., Struthere J.K., Erasmus M.J., Shepherd S.P., McGillivry G.M., Shepherd A.J., Hummitzsch D.E., Erasmus B.J., and Barnard B.J.H. Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep. J. Hyg. 97 (1986) 331-346
35. Turrel M.J., Bailey C.L., and Beaman J.R. Vector competence of a Houston Texas strain of Aedes albopictus for Rift Valley fever virus. J. Am. Mosq. Control Assoc. 4 (1998) 94-98
36. Vapalahti O., Kallio-Kokko H., Narvanen A., Julkunen I., Lundkvist A., Plyusnin A., Lehvaslaiho H., Brummer-Korvenkontio M., Vaheri A., and Lankinen H. Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J. Med. Virol. 46 (1995) 293-303
37. Vizard A.L., Anderson G.A., and Gasser R.B. Determination of the optimum cut-off value of a diagnostic test. Prev. Vet. Med. 10 (1990) 137-143
38. Woods C.W., Karpati A.M., Grein T., McCarthy N., Gaturuku P., Muchiri E., Dunster L., Henderson A., Khan A.S., Swanepoel R., Bonmarin I., Martin L., Mann P., Smoak B.L., Ryan M., Ksiazek T.G., Arthur R.R., Ndikuyeze A., Agata N.N., and Peters C.J. World Health Organization Hemorrhagic Fever Task Force. An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98. Emerg. Infect. Dis. 8 (2002) 138-144